Oil

Big Pharma: Where's the Risk Management?

You seem to be mixing up information. The Metcontrol gum is not the same as Oral-Lyn. The gum is not insulin, it is a new way of delivering Metcontrol which is different from insulin (but sometimes used in combination with it). There is no chewing of 10 pieces... A mere two pieces of the gum was found to be interchangeable with one tablet. Interchangeable means you can use either because the results are the same.

Additionally many small biotech firms have money problems until they put out a winning product.

Lastly, no I do not wonder why Generex's sales are negligible in Peru because they're not sold in Peru. But I do often wonder why people who have nothing but negative comments about a company/stock follow along with the blog posts. I think it's because you lost a lot of money in it by timing a trade poorly and want to see what the stock does next, or maybe just whine. When speculating on stocks you win some and you lose some.


On Jul 07 10:59 PM Jolly_Rancher wrote:

> Sure buccal absorption works. Absolutely. But how much insulin is
> required to lower blood sugar level? The answer is about somewhere
> between 5 and 10 times the amount consumed using injection. Have
> you bothered to read the studies? Haven't you wondered by now why
> "sales" in Peru are negligible? The answer is people have tried Oral-lyn
> gum and are tired of chewing ten pieces of gum to reach desired blood
> sugar level. The cost in money and time is too much. GNBT is a company
> constantly on the edge of bankruptcy spered time and again by pumpers
> who help the company issue new shares to feed the extremely overpaid
> upper management. Good luck!

Big Pharma: Where's the Risk Management?

Generex has additional factors in it's favor. It's bioequivalent study has shown their "Metcontrol" chewing gum to be interchangeable with Metformin tablets. Article here; finance.yahoo.com/news... Metformin according to research is the 2nd most prescribed drug for type 2 diabetes. Generex plans to begin applying for approval in first quarter 2010. Also the wholly owned subsidiary Antigen Express claims to currently have the technology to vastly out produce the traditional method of vaccine production. Article; www.telegram.com/artic...

To upndown1313, This article does not compare Generex to Pfizer. The article simply suggests an opportunity for a big company to buy or license from Generex. And mentions the big company's failures in the insulin market. Also it's probably reckless to say Oral-Lyn will "never" get approval in a major market because the delivery method is highly variable and unreliable. If clinical trials are going well then it's hard (foolish?) to argue with results.